Last reviewed · How we verify
NCT05151354
Attachment, Patient Self-disclosure and Psychotherapy Outcome
trial testing Psychotherapy in Psychotherapy in 1,500 participants. Completed in 1 September 2021.
1 September 2021
Quick facts
| Lead sponsor | University Hospital Heidelberg |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500 |
| Start date | 1 January 2015 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 September 2021 |
Drugs / interventions tested
- Psychotherapy
Conditions studied
- Psychotherapy — all drugs for Psychotherapy →
- Attachment — all drugs for Attachment →
- Self Disclosure — all drugs for Self Disclosure →
- Treatment Outcome — all drugs for Treatment Outcome →
Sponsor
University Hospital Heidelberg
Who can join
18 and older, any sex, with Psychotherapy or Attachment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates whether within- and between-patient effects of attachment moderate the association between self-disclosure and psychotherapy outcome.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05151354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Psychotherapy
Trials testing the same drug.
- NCT06827054 — Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids · Phase 2 · not yet recruiting
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07250893 — Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression · NA · recruiting
- NCT06353282 — MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents · Phase 2 · withdrawn
Other recruiting trials for Psychotherapy
Currently open trials in the same condition.
- NCT07147205 — Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine · NA · recruiting
- NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
- NCT06674499 — Development and Evaluation of a Self-Management Model for Cancer Rehabilitation · NA · active not recruiting
- NCT04356924 — Psychological Treatment to Support the Consequences of Cognitive Impairment · NA · recruiting
- NCT05587517 — A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients · Phase 2 · recruiting
Other University Hospital Heidelberg trials
Trials by the same sponsor.
- NCT07388147 — Exercise Therapy for Multiple Myeloma Patients · NA · not yet recruiting
- NCT07348874 — Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany · not yet recruiting
- NCT07181928 — Is Mentalization-based Therapy More Effective Than Treatment-as-usual for Adolescents With Dissocial Disorders? · NA · not yet recruiting
- NCT06954623 — Partial Breast Re-irradiation for Breast Cancer · NA · recruiting
- NCT06913010 — DV 100 as a Framework for the Hospital Incident Command System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05151354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Heidelberg
- Last refreshed: 9 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05151354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing